School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland,
Adv Exp Med Biol. 2014;801:797-804. doi: 10.1007/978-1-4614-3209-8_100.
Ocular neovascularisation (ONV) is a pathological feature of many human blinding diseases. Here, we review current pharmacological therapies for these disorders and highlight emerging therapies in clinical trial for ONV. Finally, we discuss desirable characteristics of future ONV therapies, including innovative strategies for novel delivery to the back of the eye.
眼内新生血管（ONV）是许多致盲性人类疾病的病理特征。在这里，我们回顾了这些疾病的当前药理学治疗方法，并重点介绍了正在临床试验中的新兴治疗方法。最后，我们讨论了未来治疗 ONV 的理想特征，包括向眼后部位递药的创新策略。
